Alexander Tin (@Alexander_Tin) / X

Alexander Tin on X: @WHO previously said of JN.1 and other variants of interest, in its latest COVID-19 epi report: currently no reported laboratory or epidemiological reports indicating any association between VOIs/VUMs

Alexander Tin on X: This is a separate manufacturer than eye drops in current recall, of brands ranging from @CVSHealth to @riteaid That is Kilitch Healthcare, which @US_FDA recently cited for range

Alexander Tin on X: At a @NatPress webinar earlier this month @ASPRgov's Meghan Pennini said their program to offer free @pfizer Paxlovid for some Americans (e.g. @MedicareGov, uninsured) has seen low uptake

Alexander Tin on X: After restarting production last year, in wake of tornado at North Carolina plant @pfizer says in new letter published by @US_FDA it is now taking some drugs from

Alexander Tin on X: In update published today @US_FDA now warning doctors prescribing @AstraZeneca's Evusheld to inform patients of increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are

Alexander Tin on X: @US_FDA's Peter Marks said, of submissions for authorizing updated boosters in younger ages we expect to start seeing the age range dropped down into the younger age ranges

Alexander Tin on X: You'll recall @CDCgov's forecasters said in update last week that cumulative number of hospitalizations may be similar or lower compared to last season's, although we have lower confidence

Alexander Tin on X: / X

Data Insights on Citi Bike NYC Business

Expect minimum staffing requirements for nursing homes next year - The Washington Post

Alexander Tin on X: @CDCgov 's Eduardo Azziz-Baumgartner told call with testing labs this week we're hearing from some jurisdictions in New England, for example, in Massachusetts, that they're really having a